source
- Novo Nordisk shares rise as Wegovy updates improve earnings outlookNovo Nordisk reported that recent data on its obesity drug Wegovy were less negative than expected, helping the company’s earnings. The improved outlook lifted Novo Nordisk’s share price, narrowin…
- Trump executive order accelerates psychedelic drug development with priority review vouchers, funding and expanded right-to-tryPresident Trump signed an executive order that aims to speed the development and approval of psychedelic medicines. The order directs the FDA to issue priority review vouchers, expands right-to-tr…